HHS implements long-awaited 340B drug price transparency rule

HHS on Thursday announced it will implement the long-delayed final rule for enforcing 340B drug ceiling price transparency on January 1, 2019. Enforcement will be maintained through a closed website available to 340B participating hospitals and providers. Federal regulators will post drug pricing information on the site.

HHS on Thursday announced it will implement the long-delayed final rule for enforcing 340B drug ceiling price transparency on January 1, 2019. Enforcement will be maintained through a closed website available to 340B participating hospitals and providers. Federal regulators will post drug pricing information on the site. The decision ends five delays over 8 years since Congress gave HHS the ability to enforce drug price ceilings. HHS officials said the delays were made to conduct longer rulemaking. Essential Hospitals said the regulator's decision to finally implement the rule was the result of a lawsuit it and six other stakeholders, including the American Hospital Association, brought against the agency in September over the delay. "The final rule issued by HHS and the Health Resources and Services Administration is a big step toward stopping drug companies from overcharging 340B hospitals, clinics, and health centers," said Maureen Testoni, interim president and CEO of 340B Health.